Dr. Torgersen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
51 N 39th St
Philadelphia, PA 19104
Summary
- Dr. Jessie Torgersen is an infectious disease specialist in Philadelphia, PA and is affiliated with multiple hospitals in the area, including Penn Presbyterian Medical Center, Hospital of the University of Pennsylvania, Philadelphia Veterans Affairs Medical Center, and Good Shepherd Penn Partners Specialty Hospital at Rittenhouse. She received her medical degree from Wayne State University School of Medicine and has been in practice 12 years. She specializes in HIV/AIDS medicine and is experienced in infective endocarditis, hepatitis B, hepatitis C, and non-alcoholic fatty liver disease among people with HIV.
Education & Training
- University of Pennsylvania Health SystemFellowship, Infectious Disease, 2013 - 2015
- Emory University School of MedicineResidency, Internal Medicine, 2010 - 2013
- Wayne State University School of MedicineClass of 2010
- University of PennsylvaniaMSCE
- Johns Hopkins Bloomberg School of Public HealthMHS
- University of California, Santa BarbaraBS, BA
Certifications & Licensure
- PA State Medical License 2013 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Study of Oral TLR8 Agonist Selgantolimod on HBsAg in Participants With Both Chronic Hepatitis B and HIV Start of enrollment: 2023 May 05
- Integrated Care and Treatment for Severe Infectious Diseases and Substance Use Disorders Among Hospitalized Patients Start of enrollment: 2024 Jan 05
Publications & Presentations
PubMed
- Hepatotoxicity Score: A New Method to Adjust for Use of Potentially Hepatotoxic Medications by Chronic Liver Disease Status.Vincent Lo Re 3rd, Craig W Newcomb, Dean M Carbonari, Alyssa K Mezochow, Sean Hennessy
Pharmacoepidemiology and Drug Safety. 2024-12-01 - Risk Score for Hepatocellular Cancer in Adults Without Viral Hepatitis or Cirrhosis.Ysabel C Ilagan-Ying, Kirsha S Gordon, Janet P Tate, Joseph K Lim, Jessie Torgersen
JAMA Network Open. 2024-11-04 - Risk of Liver Injury With Potentially Hepatotoxic Drugs-Reply.Vincent Lo Re 3rd, Jessie Torgersen, Amy C Justice
JAMA Internal Medicine. 2024-11-04
Journal Articles
- Enhancing Hepatitis B Care Competency through Project ECHO: A Program EvaluationFreeland C, Bruckbauer J, Qureshi A, Huynh K, Rutland M, Fenkel JM, Torgersen J, Rothstein K, Gish R, Cohen C, J Dig Dis Hepatol, 12/27/2023
Books/Book Chapters
Abstracts/Posters
- Clinic Screening for Adverse Childhood Experiences among Persons with HIV: a Pilot Project. IDWeek 2019Anand P, Carter B, Bronstein A, Schwartz A, Harrington B, Wilson J, Metzger D, Short W, Torgersen J, ID Week, Washington, DC, 10/3/2019
- Adverse Childhood Experiences (ACEs) Screening and Referral to Care in an HIV Primary Care Clinic: A Pilot Project in Quality ImprovementAnand P, Harrington B, Carter B, Bronstein A, Schwartz A, Metzger D, Short W, Torgersen J, 2019 End AIDS: The HIV Prevention and Education Summit, Philadelphia, PA, 6/11/2019
- Elimination of Hepatitis C Virus in HIV-Coinfected Patients in a Viral Hepatitis Center: A Multi-Disciplinary ApproachBinkley A, Torgersen J, Gilmore J, O’Neal J, Saine ME, Russell R, Short W, Lo Re III V, American Conference for the Treatment of HIV, Miami, FL, 4/11/2019
- Join now to see all
Lectures
- Hepatitis C Diagnosis and TreatmentPenn Medicine Infectious Disease Update for Primary Care Providers - 5/20/2022
- Hepatocellular Risk in HIVYale Virus and Other Infection-Related Cancers Summit. Yale University School of Medicine - 4/30/2019
- HIV Viremia and Low CD4+ Cell Count Predict Development of Hepatocellular Carcinoma in Early But Not Advanced Liver FibrosisConference on Retroviruses and Opportunistic Infections - 3/6/2019
- Join now to see all
Press Mentions
- Listen to "Liver Cancer Screening: A New Tool for Improved-DetectionNovember 8th, 2024
- Q&A: Emphasizing Transmission & Prevention Key to Reduce HCV Reinfection in MSM with HIVOctober 29th, 2024
- Most Potentially Hepatotoxic Meds Revealed: Real-World Data AnalysisJuly 16th, 2024
- Join now to see all
Grant Support
- Use of Deep Learning Algorithms to Enable Evaluation of the Determinants and Outcomes of Hepatic Steatosis, by HIV StatusNational Institute of Diabetes and Digestive and Kidney Disease2022–2027
Committees
- Co-Chair, IDSA Grants for Emerging Researchers/Clinicians Mentorship Program 2024 - Present
- Member, AASLD/IDSA HCV Guidance Panel 2023 - Present
Professional Memberships
- Member
- Fellow
- American Association for the Study of Liver DiseasesMember
- American Society for MicrobiologyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: